申请人:——
公开号:US20020028833A1
公开(公告)日:2002-03-07
Aryl alkenamides derivatives of Formula I or a pharmaceutically acceptable salt thereof are novel MCP-1 antagonists and are thus useful in the treatment of inflammation, atherosclerosis, restenosis, and immune disorders such as arthritis and transplant rejection
1
V=O, S, NH or a bond;
Ar can be unsubstituted or substituted benzimidazole, phenyl, biphenyl, pyridyl, naphthyl, quinoline, isoquinoline or indole;
n=2-6;
m=1-3;
X=O (oxygen), S (sulfur), ═CH
2
, ═NH or H
2
;
R
1
and R
2
can independently be hydrogen,
lower alkyl of from 1-4 carbon atoms,
—(CH
2
)
n
OR
6
,
—(CH
2
)
n
NR
3
R
4
,
—(CH
2
)
n
′CONR
3
R
4
,
—(CH
2
)
n
′COOR
6
,
—(CH
2
)
r
Ar′,
where
n′=0-6
r=0-4
R
3
and R
4
can independently be hydrogen,
lower alkyl of from 1-4 carbon atoms, —(CH
2
)
n
OR
6
, or
—(CH
2
)
m
—Ar′, which can be unsubstituted or substituted with up to 3 substitutents, where “Ar′” is phenyl, pyridyl, or indole;
R
3
and R
4
may also be taken together to form a cyclic ring of 3-8 atoms which may also contain oxygen or the group NR
5
where R
5
can be
hydrogen,
lower alkyl of from 1-4 carbon atoms,
cycloalkyl of from 5-12 carbon atoms, or
—(CH
2
)
m
-Phenyl, which can be unsubstituted or substituted with up to 3 substitutents;
R
6
can be
hydrogen,
lower alkyl or (CH
2
)
m
-Phenyl;
m=1-3;
R
1
and R
2
may be also taken together to form a ring of 3-8 atoms which may also contain oxygen or the group NR
5
, which ring may be substituted on one or more carbon atoms with the group NR
3
R
4
;
the subtituents are defined as:
halogen,
nitro,
CF
3
,
alkyl of from 1-12 carbon atoms;
—(CH
2
)
r
OR
6
—(CH
2
)
r
NR
3
R
4
—(CH
2
)
r
CONR
3
R
4
—(CH
2
)
r
C(O)OR
6
or
—(CH
2
)
r
SO
2
—OR
6
;
R
7
, R
8
, R
9
and R
10
can each independently be hydrogen, lower alkyl or aryl;
and R
7
and R
8
or R
9
and R
10
or X or R
2
when taken together can form a 5-7 membered ring including cycloalkyl, cycloalkenyl, aryl, or heteroaryl containing nitrogen, oxygen or sulfur.
公式I的芳基烯酰胺衍生物或其药学上可接受的盐是新型MCP-1拮抗剂,因此在治疗炎症、动脉粥样硬化、再狭窄和免疫紊乱,如关节炎和移植排斥方面有用。其中,V=O,S,NH或键;Ar可以是未取代或取代苯并咪唑、苯基、联苯基、吡啶基、萘基、喹啉、异喹啉或吲哚;n=2-6;m=1-3;X=O(氧)、S(硫)、═CH2、═NH或H2;R1和R2可以独立地是氢、1-4碳原子的低烷基、—(CH2)nOR6、—(CH2)nNR3R4、—(CH2)n′CONR3R4、—(CH2)n′COOR6、—(CH2)rAr′,其中n=0-6,r=0-4;R3和R4可以独立地是氢、1-4碳原子的低烷基、—(CH2)nOR6或—(CH2)m—Ar′,其中“Ar′”可以是未取代或取代的苯基、吡啶基或吲哚,最多可以带有3个取代基;R3和R4也可以结合成为3-8个原子的环,该环也可以包含氧或基团NR5,其中R5可以是氢、1-4碳原子的低烷基、5-12碳原子的环烷基或—(CH2)m-苯基,最多可以带有3个取代基;R6可以是氢、低烷基或(CH2)m-苯基;m=1-3;R1和R2也可以结合成为3-8个原子的环,该环也可以包含氧或基团NR5,在其中一个或多个碳原子上取代基团NR3R4;取代基团的定义为:卤素、硝基、CF3、1-12碳原子的烷基;—(CH2)rOR6、—(CH2)rNR3R4、—(CH2)rCONR3R4、—(CH2)rC(O)OR6或—(CH2)rSO2—OR6;R7、R8、R9和R10可以各自独立地是氢、低烷基或芳基;当R7和R8或R9和R10或X或R2结合在一起时,可以形成一个包含氮、氧或硫的5-7个成员的环,包括环烷基、环烯基、芳基或杂芳基。